CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 119

Industry reads hand-picked by our editors

Apr 21, 2022

Bloomberg Law
Brewing Alzheimer's Drug Plan Fights Rest in Patients' Hands
Reuters
GSK workers vote to strike over pay dispute
Politico
Waiting for a Covid vaccine for your under-five kid? It may take a bit longer.

Apr 20, 2022

Financial Times
Moderna and Pfizer urged to share vaccine technology with developing world
Bloomberg
Chinese Biotech I-Mab Weighing Options Including Sale
C&EN
EuroAPI is ready to emerge from Sanofi’s shadow
FiercePharma
As safety signals mount, FDA aims to crack down on PI3K blood cancer nods

Apr 19, 2022

STAT
Moderna data yield hope for better Covid-19 booster shots
The New York Times
Scientists Question Data Behind an Experimental Alzheimer's Drug
FierceBiotech
Axsome Therapeutics' major depressive disorder drug steps closer to approval

Apr 18, 2022

Reuters
The case for testing Pfizer's Paxlovid for treating long COVID
The Wall Street Journal
Pfizer, Moderna, J&J See Respiratory Virus RSV as Next Vaccine Target
NPR
Researchers explore an unlikely treatment for cognitive disorders: video games
C&EN
Targeted radioactive drugs raise hopes for treating cancer

Apr 14, 2022

Fierce Pharma
AbbVie president Severino departs to help pilot Flagship Pioneering
LifeSciVC
Responding To Tough Markets: Restructurings In Biotech
MarketWatch
Adagio Pauses Approval Application on Covid Drug, Based on FDA Feedback

Apr 13, 2022

The New York Times
McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulators
Bloomberg
Aduhelm Coverage Decision Won’t Govern All Fast-Track Approvals, Official Says
Evaluate Vantage
Novartis's late Kras challenge to Amgen

Apr 12, 2022

Reuters
Novartis to cut thousands of jobs in global revamp
Associated Press
Can cancer blood tests live up to promise of saving lives?
Bloomberg
India Hopes 'Pharma City' Will Break China's Grip on Drug Industry
STAT
Black health-equity advocate named JAMA editor-in-chief

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Trendline
Inside the world of cell therapies Supported by 10x Genomics
Infographic
Accelerate clinical trials: Break silos, reduce delays Custom content for WCG
Survey Report
Data Science Drives 78% Growth in Drug Discovery by 2028 Custom content for Qiagen

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Peptides Under Pressure: Analytical Challenges in a High-Stakes Market Webinar - on demand • Provided by Solvias
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID
Trends and Innovations in Life Science Qualitative Research Webinar - on demand • Provided by Konovo

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.